Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation.
about
Platelets in Pulmonary Immune Responses and Inflammatory Lung DiseasesPlatelet Interaction with Innate Immune CellsCurrent challenges in understanding immune cell functions during septic syndromesEmerging roles for platelets as immune and inflammatory cellsIntercellular Interactions as Regulators of NETosisPlatelets in inflammation and atherogenesisInteraction of the antimicrobial peptide polymyxin B1 with both membranes of E. coli: a molecular dynamics studyThe Brassicaceae species Heliophila coronopifolia produces root border-like cells that protect the root tip and secrete defensin peptides.Human platelets efficiently kill IgG-opsonized E. coliCrosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesBacteria differentially induce degradation of Bcl-xL, a survival protein, by human plateletsPlatelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcomePlatelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.In vitro induction of NETosis: Comprehensive live imaging comparison and systematic reviewPerspectives for clinical use of engineered human host defense antimicrobial peptidesSepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study.Expression and antimicrobial function of beta-defensin 1 in the lower urinary tractA novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia.Platelets and infections - complex interactions with bacteria.The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps.Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study.Systemic Inflammatory Response Syndrome After Contentious-Flow Left Ventricular Assist Device Implantation and Change in Platelet Mitochondrial Membrane Potential.Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo.Higher platelet reactivity and platelet-monocyte complex formation in Gram-positive sepsis compared to Gram-negative sepsis.Early type I Interferon response induces upregulation of human β-defensin 1 during acute HIV-1 infection.Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis.NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury.Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity.Platelets as cellular effectors of inflammation in vascular diseases.Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxinPlatelets: essential components of the immune system.Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis.Antimicrobial peptide elicitors: new hope for the post-antibiotic era.Platelets: bridging hemostasis, inflammation, and immunity.Neutrophil extracellular traps as a new paradigm in innate immunity: friend or foe?Platelets as immune cells in infectious diseases.Targeting the host hemostatic system function in bacterial infection for antimicrobial therapies.Platelets in inflammation and immunity.Platelet transfusion - the new immunology of an old therapy.Platelets in leucocyte recruitment and function.
P2860
Q26739670-320CAF96-D914-468C-AB04-571F1E063244Q26745910-CA7AB6BD-0656-49A0-9266-FF21C4AD4E9AQ26849252-E559A41C-79EA-4B22-AFE4-907007525009Q27016553-88AB16EC-0B38-4E8B-99EE-BDE930A1A6DDQ28078773-4787E802-5E95-45E6-A950-5DFEF4F50164Q28085020-FFC8606A-7B6D-4B3B-91B3-95770AB9A9E8Q28546494-5CFC719C-EA6C-4730-A699-25BB32B63B6EQ33363617-14A2ED3C-330B-42A4-8072-EF4801251D9AQ33399755-0D4DB20C-07C0-4A4D-A673-E865C1DF9D6CQ33403517-F3C2DCF3-76ED-4EA1-8B2A-AA0AF2863598Q33403953-72A92939-5CE5-4B75-8DD4-5AA78E6D44D5Q33413307-3A46D3D9-93D1-422F-8DD6-2A8FEAB94EAAQ33432917-4518F4F4-7164-4CA8-ABBA-1058E8395B51Q33652975-5C689163-40F9-4A84-8049-80D16250B85EQ33700825-F6207514-ABE2-4DFB-BA54-E7494D1374E1Q33894675-F4585386-792E-4BF3-81AC-7507461D0447Q35035519-A8710A03-140F-46E6-A5CC-A0AD2250388EQ35060782-68BCE4E2-8DAD-455C-8BB2-C7455EEBA9C4Q35124418-A24E4DBC-9156-451A-89CB-7506234C7A42Q35236953-6443DB09-D81C-4C8E-8D65-BC610028E216Q35261088-3E464AA3-AFF5-4DCD-8E52-852359E6D997Q35842168-52060E79-C648-4B4F-BD95-AEDF72AAD812Q36038084-5D2C6112-F349-44C6-912D-312B286BF036Q36235371-17DF89CC-BE8F-4C19-9E85-608FCF925F3DQ36295386-90FAA0CE-A163-47F3-98CC-894BE40667EBQ36429121-BFF4A4CB-9F4E-455C-8BD4-74A6891164B4Q36647903-C1B7AE97-6369-4047-B82D-1705BA400448Q36690057-562BD247-4312-4786-A072-072378DC75FCQ37081746-7B8EC530-9DA4-4FBB-BCEF-7C36C10AB6E9Q37250664-B3ACC7AE-4A2A-4627-8DA1-32555C1CF3E6Q37395743-B092A9AC-0D57-4CF2-AF7D-F07DB7AF87C0Q37729004-4B6768BC-0DC0-415E-9313-CDD9B44FEC51Q38060524-FC9FFD70-79B5-4C04-981B-B2614C9E6182Q38099418-89A3327C-24A8-4DE1-8751-E56B1E5679EBQ38127783-4CFFA4E5-2872-4322-B1F4-53CC7BCB2357Q38160535-790EF60D-B36B-49A0-B287-9600F39124C1Q38174837-90E361C8-D4A3-4EEF-AB4A-DC5F87E5BDE3Q38249957-AEE9F07A-0D34-48BF-BB79-0E0A05BC5F2AQ38362628-AAF73470-BE8D-47DA-A0BC-C83DE8C31B9EQ38364980-FECFA2C1-2E41-4CA8-8E13-2BE62026A1A7
P2860
Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel anti-bacterial activitie ...... extracellular trap formation.
@ast
Novel anti-bacterial activitie ...... extracellular trap formation.
@en
Novel anti-bacterial activitie ...... extracellular trap formation.
@nl
type
label
Novel anti-bacterial activitie ...... extracellular trap formation.
@ast
Novel anti-bacterial activitie ...... extracellular trap formation.
@en
Novel anti-bacterial activitie ...... extracellular trap formation.
@nl
prefLabel
Novel anti-bacterial activitie ...... extracellular trap formation.
@ast
Novel anti-bacterial activitie ...... extracellular trap formation.
@en
Novel anti-bacterial activitie ...... extracellular trap formation.
@nl
P2093
P2860
P1433
P1476
Novel anti-bacterial activitie ...... l extracellular trap formation
@en
P2093
Bjoern F Kraemer
Christian C Yost
Guy A Zimmerman
Hansjörg Schwertz
Mark J Cody
Neal D Tolley
Peter Seizer
Robert A Campbell
Stephan Lindemann
Walter H A Kahr
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002355
P50
P577
2011-11-10T00:00:00Z